Benitec Biopharma Overview

  • Founded
  • 1995
Founded
  • Status
  • Public
  • Employees
  • 14
Employees
  • Stock Symbol
  • BNTC
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $4.23
  • (As of Thursday Closing)

Benitec Biopharma General Information

Description

Benitec Biopharma Inc is a biotechnology company developing a proprietary therapeutic technology platform that combines RNA interference with gene therapy for providing sustained, long-lasting silencing of disease-causing genes from a single administration. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The company is developing product candidates in chronic and life-threatening human disease areas including Orphan disease: Oculopharyngeal Muscular Dystrophy (OPMD) and Infectious disease: Hepatitis B Virus (HBV).

Contact Information

Website
www.benitec.com
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Stock Exchange
NAS
Primary Office
  • 3940 Trust Way
  • Hayward, CA 94545
  • United States

Benitec Biopharma Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Benitec Biopharma Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$4.23 $4.37 $2.30 - $12.52 $35.7M 8.17M 2.78M -$5.67

Benitec Biopharma Financials Summary

In Thousands,
USD
TTM 31-Mar-2021 FY 2020 30-Jun-2020 FY 2019 30-Jun-2019 FY 2018 30-Jun-2018
EV 11,210 14 (16,301) (8,045)
Revenue 57 97 11,551 293
EBITDA (12,411) (7,962) 2,645 (9,054)
Net Income (12,814) (8,274) 2,609 (9,016)
Total Assets 13,428 11,587 19,235 15,675
Total Debt 262 405 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Benitec Biopharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Benitec Biopharma‘s full profile, request access.

Request a free trial

Benitec Biopharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Benitec Biopharma Inc is a biotechnology company developing a proprietary therapeutic technology platform that combines
Drug Discovery
Hayward, CA
14 As of 2020
000.00
00000000 000.00

00000000

dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore m
0000000000000
Baltimore, MD
000 As of 0000
00000
0000 0000-00-00
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Benitec Biopharma Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
00000000 000000 00 Venture Capital-Backed Baltimore, MD 000 00000 00000000000 00000
You’re viewing 1 of 1 competitors. Get the full list »

Benitec Biopharma Executive Team (11)

Name Title Board Seat Contact Info
Jerel Banks Ph.D Chief Executive Officer, Executive Chairman and Board Member
Megan Boston Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Oliver Kidd Board Member & Company Secretary
Claudia Kloth Ph.D Senior Vice President, Manufacturing
You’re viewing 4 of 11 executive team members. Get the full list »

Benitec Biopharma Board Members (8)

Name Representing Role Since
000000 00000 Self Board Member 000 0000
0. 00000 Self Board Member 000 0000
00000 00000 00.0 Benitec Biopharma Chief Executive Officer, Executive Chairman and Board Member 000 0000
00000 00000 Benitec Biopharma Board Member 000 0000
000 0000000 Self Director 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Benitec Biopharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Benitec Biopharma Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Benitec Biopharma‘s full profile, request access.

Request a free trial

Benitec Biopharma Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 00000000000 30-Oct-2012 000000000000000000 00.00 Drug Discovery
To view Benitec Biopharma’s complete acquisitions history, request access »

Benitec Biopharma Subsidiaries (1)

Company Name Industry Location Founded
000000 00000000000 Drug Discovery Pleasanton, CA 0000
To view Benitec Biopharma’s complete subsidiaries history, request access »